{"doi":"10.1093/infdis/jiaa049","title":"Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children","abstract":"BACKGROUND: Respiratory syncytial virus (RSV) is the leading viral cause of severe pediatric respiratory illness, and vaccines are needed. Live RSV vaccine D46/NS2/N/ΔM2-2-HindIII, attenuated by deletion of the RSV RNA regulatory protein M2-2, is based on previous candidate LID/ΔM2-2 but incorporates prominent differences from MEDI/ΔM2-2, which was more restricted in replication in phase 1. METHODS: RSV-seronegative children aged 6-24 months received 1 intranasal dose (105 plaque-forming units [PFUs] of D46/NS2/N/ΔM2-2-HindIII [n = 21] or placebo [n = 11]) and were monitored for vaccine shedding, reactogenicity, RSV-antibody responses and RSV-associated medically attended acute respiratory illness (RSV-MAARI) and antibody responses during the following RSV season. RESULTS: All 21 vaccinees were infected with vaccine; 20 (95%) shed vaccine (median peak titer, 3.5 log10 PFUs/mL with immunoplaque assay and 6.1 log10 copies/mL with polymerase chain reaction). Serum RSV-neutralizing antibodies and anti-RSV fusion immunoglobulin G increased ≥4-fold in 95% and 100% of vaccines, respectively. Mild upper respiratory tract symptoms and/or fever occurred in vaccinees (76%) and placebo recipients (18%). Over the RSV season, RSV-MAARI occurred in 2 vaccinees and 4 placebo recipients. Three vaccinees had ≥4-fold increases in serum RSV-neutralizing antibody titers after the RSV season without RSV-MAARI. CONCLUSIONS: D46/NS2/N/ΔM2-2-HindIII had excellent infectivity and immunogenicity and primed vaccine recipients for anamnestic responses, encouraging further evaluation of this attenuation strategy. CLINICAL TRIALS REGISTRATION: NCT03102034 and NCT03099291.","journal":"The Journal of Infectious Diseases","year":2020,"id":65483,"datarank":1.8364812260710908,"base_score":4.060443010546419,"endowment":4.060443010546419,"self_citation_contribution":0.6090664515819629,"citation_network_contribution":1.227414774489128,"self_endowment_contribution":0.6090664515819629,"citer_contribution":1.227414774489128,"corpus_percentile":null,"corpus_rank":null,"citation_count":57,"citer_count":50,"citers_with_citation_signal":39,"citers_with_endowment":39,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9554,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT03102034","NCT03099291"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":346910,"name":"Ruth A. Karron","orcid":"0000-0002-4448-4946","position":1,"is_corresponding":false},{"id":349133,"name":"Petronella Muresan","orcid":null,"position":2,"is_corresponding":false},{"id":325730,"name":"Coleen K. Cunningham","orcid":"0000-0002-7725-3052","position":3,"is_corresponding":false},{"id":349134,"name":"Charlotte Perlowski","orcid":null,"position":4,"is_corresponding":false},{"id":349135,"name":"Jennifer Libous","orcid":null,"position":5,"is_corresponding":false},{"id":349136,"name":"Jennifer Oliva","orcid":null,"position":6,"is_corresponding":false},{"id":349137,"name":"Patrick Jean‐Philippe","orcid":null,"position":7,"is_corresponding":false},{"id":346911,"name":"Jack Moye","orcid":"0000-0001-9976-8586","position":8,"is_corresponding":false},{"id":349138,"name":"Elizabeth Schappell","orcid":null,"position":9,"is_corresponding":false},{"id":346912,"name":"Emily Barr","orcid":"0000-0002-3578-3389","position":10,"is_corresponding":false},{"id":349139,"name":"Vivian Rexroad","orcid":null,"position":11,"is_corresponding":false},{"id":349140,"name":"Laura Fearn","orcid":null,"position":12,"is_corresponding":false},{"id":349141,"name":"Mikhaela Cielo","orcid":null,"position":13,"is_corresponding":false},{"id":346913,"name":"Andrew Wiznia","orcid":"0000-0001-7487-1894","position":14,"is_corresponding":false},{"id":346914,"name":"Jaime G. Deville","orcid":"0000-0002-7523-0658","position":15,"is_corresponding":false},{"id":346915,"name":"Lijuan Yang","orcid":"0000-0001-6388-6695","position":16,"is_corresponding":false},{"id":346916,"name":"Cindy Luongo","orcid":"0000-0002-3830-3803","position":17,"is_corresponding":false},{"id":80811,"name":"Peter L. Collins","orcid":"0000-0001-7543-7299","position":18,"is_corresponding":false},{"id":235602,"name":"Ursula J. Buchholz","orcid":"0000-0002-2329-3198","position":19,"is_corresponding":false},{"id":346909,"name":"Elizabeth J. McFarland","orcid":"0000-0003-0653-8955","position":0,"is_corresponding":true}],"reference_count":27,"raw_metadata":null,"created_at":"2026-07-18T21:13:43.728351Z","pmid":"32006006","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}